Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Castiglione-Gertsch M, Johnsen C, Goldhirsch A, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Hacking A, Cortes-Funes H, Forbes J, et al. Castiglione-Gertsch M, et al. Among authors: collins j. Ann Oncol. 1994 Oct;5(8):717-24. doi: 10.1093/oxfordjournals.annonc.a058976. Ann Oncol. 1994. PMID: 7826904 Free article. Clinical Trial.
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Goldhirsch A, Gelber RD, Price KN, Castiglione M, Coates AS, Rudenstam CM, Collins J, Lindtner J, Hacking A, Marini G, et al. Goldhirsch A, et al. Among authors: collins j. Lancet. 1994 Feb 12;343(8894):377-81. doi: 10.1016/s0140-6736(94)91221-1. Lancet. 1994. PMID: 7905550 Clinical Trial.
Present and future projects of the International Breast Cancer Study Group.
Goldhirsch A, Gelber RD, Castiglione M, Price KN, Rudenstam CM, Lindtner J, Collins J, Senn HJ, Brunner KW, Galligioni E, et al. Goldhirsch A, et al. Among authors: collins j. Cancer. 1994 Aug 1;74(3 Suppl):1139-49. doi: 10.1002/1097-0142(19940801)74:3+<1139::aid-cncr2820741524>3.0.co;2-k. Cancer. 1994. PMID: 8039150
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).
Spataro V, Price K, Goldhirsch A, Cavalli F, Simoncini E, Castiglione M, Rudenstam CM, Collins J, Lindtner J, Gelber RD. Spataro V, et al. Among authors: collins j. Ann Oncol. 1992 Nov;3(9):733-40. doi: 10.1093/oxfordjournals.annonc.a058330. Ann Oncol. 1992. PMID: 1450062 Free article.
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG).
Crivellari D, Price KN, Hagen M, Goldhirsch A, Gelber RD, Castiglione M, Coates AS, Rudenstam CM, Collins J, Lindtner J, et al. Crivellari D, et al. Among authors: collins j. Ann Oncol. 1995 Oct;6(8):769-76. doi: 10.1093/oxfordjournals.annonc.a059314. Ann Oncol. 1995. PMID: 8589013 Free article. Clinical Trial.
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.
Marini G, Murray S, Goldhirsch A, Gelber RD, Castiglione-Gertsch M, Price KN, Tattersall MH, Rudenstam CM, Collins J, Lindtner J, Cavalli F, Cortés-Funes H, Gudgeon A, Forbes JF, Galligioni E, Coates AS, Senn HJ. Marini G, et al. Among authors: collins j. Ann Oncol. 1996 Mar;7(3):245-50. doi: 10.1093/oxfordjournals.annonc.a010567. Ann Oncol. 1996. PMID: 8740787 Free article. Clinical Trial.
7,387 results